New partner for the Swiss cannabis market
The Swiss pharmaceutical distributor Astrasana has reached an important business agreement. The company has secured exclusive rights for the distribution of genetics from the Canadian cannabis producer Green Karat in Switzerland.
This partnership is a significant step for the growing medical cannabis market in Switzerland. Through this collaboration, Astrasana gains access to high-quality plant genetics from Canada, which are now to be used specifically for the Swiss market.
The cooperation between the Canadian producer and the Swiss company shows how the industry is networking internationally. In this, Astrasana assumes a central role in the distribution of these specialized products to customers and partners within Switzerland.
For patients and professionals in the field of cannabis medicine, this step could lead to a broader range of offerings in the long term. The industry is monitoring the development closely, as the demand for controlled and high-quality cannabis products in Switzerland is steadily increasing.